Logo image of AVCO

AVALON GLOBOCARE CORP (AVCO) Stock Analyst Earnings Estimates

NASDAQ:AVCO - Nasdaq - US05344R1041 - Common Stock - Currency: USD

0.5259  -0.1 (-16.52%)

After market: 0.601 +0.08 (+14.28%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021
Revenue
YoY % growth
AVCO revenue by date.AVCO revenue by date.
1.546M
-1.02%
1.378M
-10.90%
1.391M
0.96%
EBITDA
YoY % growth
AVCO ebitda by date.AVCO ebitda by date.
-17.86M
-151.26%
-12.139M
32.03%
-7.147M
41.12%
EBIT
YoY % growth
AVCO ebit by date.AVCO ebit by date.
-18.367M
-140.69%
-12.454M
32.19%
-7.459M
40.11%
Operating Margin
AVCO operating margin by date.AVCO operating margin by date.
-1,187.81%-903.93%-536.23%
EPS
YoY % growth
AVCO eps by date.AVCO eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth
290.82K
3.78%
%
Q1 2022
Q2Q % growth
297.63K
2.63%
%
Q4 2021
Q2Q % growth
334.2K
-25.73%
%
Q3 2021
Q2Q % growth
486.76K
52.11%
%
Q2 2021
Q2Q % growth
280.23K
-6.59%
%
Q1 2021
Q2Q % growth
290K
-3.33%
%
Q4 2020
Q2Q % growth
450K
-6.25%
%
Q3 2020
Q2Q % growth
320K
-15.79%
%
Q2 2020
Q2Q % growth
300K
-25.00%
%
Q1 2020
Q2Q % growth
300K
7.14%
%
AVCO Yearly Revenue VS EstimatesAVCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 500K 1M 1.5M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A